Vaccine composition

Details for Australian Patent Application No. 2012201827 (hide)

Owner Glaxo Group Limited

Inventors Ertl, Peter Franz; Tite, John Philip; Van Wely, Catherine Ann

Agent Shelston IP

Pub. Number AU-A-2012201827

Parent 2006245920

Filing date 28 March 2012

Wipo publication date 19 April 2012

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 April 2012 Complete Application Filed

19 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201827

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201828-Method, system and device of phase identification using a smart meter

2012201826-Electronic commerce system, method and apparatus